2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy And Planning 2018, 33: 528-538. PMID: 29529282, PMCID: PMC5894072, DOI: 10.1093/heapol/czy018.Peer-Reviewed Original Research
2012
Vaccine research and development
Hecht R, Jamison D, Augenstein J, Partridge G, Thorien K. Vaccine research and development. 2012, 299-334. DOI: 10.1017/cbo9781139236805.009.Peer-Reviewed Original ResearchAIDS vaccineInternational AIDS Vaccine InitiativeAnti-retroviral therapyImmune deficiency syndromeAIDS vaccine developmentTime AIDSHIV infectionDeficiency syndromeVaccine researchNew infectionsVaccine InitiativeVaccine developmentTreatment programInfectious diseasesVaccineInfectionPercent efficacyAIDSPreventionEpidemicTreatmentYearsPercentUniversal accessHIV
2011
Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLOS ONE 2011, 6: e25310. PMID: 21998648, PMCID: PMC3187775, DOI: 10.1371/journal.pone.0025310.Peer-Reviewed Original ResearchConceptsMiddle-income countriesAIDS treatmentProgram costsIncome countriesLarge health gainsAntiretroviral therapyHIV infectionOpportunistic infectionsGlobal FundLife careMedical treatmentAIDS diseaseTreatment programHealth gainsCurrent cohortTotal program costsTreatmentPatientsCohortInfectionCareEnd 2011Same periodEconomic benefitsLabor productivity effects
2007
The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results
Stover J, Bollinger L, Hecht R, Williams C, Roca E. The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results. Health Affairs 2007, 26: 1147-1158. PMID: 17630459, DOI: 10.1377/hlthaff.26.4.1147.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesDeveloping CountriesDisease SusceptibilityDrug EvaluationFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedModels, StatisticalPatient SelectionProbabilityResearch Support as TopicRisk AssessmentRisk FactorsRisk-TakingSexual BehaviorSubstance Abuse, Intravenous